Eric Trump Announces American Bitcoin Launch, Lauds BTC As ‘Modern-Day Gold’
Eric Trump, co-founder and chief strategy officer at American Bitcoin Corp. (NASDAQ:ABTC) has lauded blockchain adoption as the future read more
Read More
FDA Flags Eli Lilly’s Weight-Loss Drug Video For Misleading Claims
The FDA finds Eli Lilly’s video on Zepbound and Mounjaro misleading, citing omissions of serious risks. read more
What Is Going On With Broadcom Stock On Tuesday?
Custom Application-Specific Integrated Circuits (ASICs) provider Broadcom (NASDAQ:AVGO) trended on Tuesday as the Big Tech giants (including Microsoft Corp (NASDAQ: MSFT), Alphabet Inc. (NASDAQ: Latest Ratings for AVGO Date Firm Action From To Mar 2022 Truist Securities Maintains Buy Mar 2022 JP Morgan Maintains Overweight Mar 2022 Morgan Stanley Maintains Overweight View More Analyst Ratings for…
Colgate Agrees To Show Safe Toothpaste Amounts For Kids After Legal Pressure
Attorney General Paxton secured a deal with Colgate to ensure kids’ toothpaste ads show safe, age-appropriate amounts starting in November 2025.. read more
Where nVent Electric Stands With Analysts
Latest Ratings for NVT Date Firm Action From To Feb 2022 Barclays Maintains Overweight Jan 2022 Vertical Research Upgrades Hold Buy Oct 2021 Keybanc Maintains Overweight View More Analyst Ratings for NVT View the Latest Analyst Ratings read more
Forecasting The Future: 6 Analyst Projections For Golden Entertainment
Latest Ratings for GDEN Date Firm Action From To Feb 2022 Deutsche Bank Maintains Buy Feb 2022 Macquarie Maintains Outperform Oct 2021 JP Morgan Initiates Coverage On Overweight View More Analyst Ratings for GDEN View the Latest Analyst Ratings read more
What Analysts Are Saying About Strategy Stock
Latest Ratings for MSTR Date Firm Action From To Jul 2021 BTIG Maintains Buy Jul 2021 Canaccord Genuity Maintains Buy Jun 2021 Citigroup Maintains Sell View More Analyst Ratings for MSTR View the Latest Analyst Ratings read more
Hims & Hers Scrutinized For Marketing Its Product As Similar To Ozempic, Wegovy
FDA warns Hims & Hers that its semaglutide products are misbranded due to misleading claims and asks for corrective steps within 15 days. read more
